Cargando…
Xenograft Zebrafish Models for the Development of Novel Anti-Hepatocellular Carcinoma Molecules
Hepatocellular carcinoma (HCC) is the sixth most common type of tumor and the second leading cause of tumor-related death worldwide. Liver cirrhosis is the most important predisposing factor for HCC. Available therapeutic approaches are not very effective, especially for advanced HCC, which is the m...
Autores principales: | Tonon, Federica, Farra, Rossella, Zennaro, Cristina, Pozzato, Gabriele, Truong, Nhung, Parisi, Salvatore, Rizzolio, Flavio, Grassi, Mario, Scaggiante, Bruna, Zanconati, Fabrizio, Bonazza, Deborah, Grassi, Gabriele, Dapas, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400454/ https://www.ncbi.nlm.nih.gov/pubmed/34451900 http://dx.doi.org/10.3390/ph14080803 |
Ejemplares similares
-
Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches
por: Jesenko, Tanja, et al.
Publicado: (2023) -
Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals
por: Bosutti, Alessandra, et al.
Publicado: (2016) -
Polymer-Mediated Delivery of siRNAs to Hepatocellular Carcinoma: Variables Affecting Specificity and Effectiveness
por: Farra, Rossella, et al.
Publicado: (2018) -
An Overview of siRNA Delivery Strategies for Urological Cancers
por: Halib, Nadia, et al.
Publicado: (2022) -
Dissecting the expression of EEF1A1/2 genes in human prostate cancer cells: the potential of EEF1A2 as a hallmark for prostate transformation and progression
por: Scaggiante, B, et al.
Publicado: (2012)